Other studies using siRNA showed that knockdown of ZNF703 expression inhibited papillary thyroid carcinoma, medullary thyroid carcinoma, and colorectal cancer cell proliferation and migration [43,48,49] comforting ZNF703 as an oncogene and a potential therapeutic target for other advanced cancers. Here, ZNF703 is linked to thyroid gland papillary carcinoma.